HiFiBiO SAS commercializes proprietary single cell technologies for applications in drug and biomarker discovery and development. Our scientific founders have deep, world-leading expertise in microfluidics, epigenetics, next-generation sequencing and bioinformatics that supports our broad, proprietary portfolio of technologies and know-how. Our seasoned executive team has a strong track record of success in building high value life science companies based on university-licensed technologies. The company has operations in Paris (France) and Boston (USA).

Focus area
Graduation date
Commencement date